http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017281548-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f3cb69a65abbbc14e3e2df44136d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9c44b93ab28b2f11710c52724d40a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13ee1e7557cce4c7ec8cfa5f8290eae5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2bddd167acd52f096fc64c47d50f873
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24a7ecf14520e450d053f60c480469d0
publicationDate 2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2017281548-A1
titleOfInvention Organic Compounds
abstract A pharmaceutical composition comprises octreotide acetate microparticles of linear poly (lactide-co-glycolide) polymer wherein the polymer contains less than 1% silicone oil or heptane.
priorityDate 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID383413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6400441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408603
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57181882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051973
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405539

Total number of triples: 45.